Pulmonary hypertension in children with sickle cell disease. - Wikidata - wikimedia - TriplyDB

Pulmonary hypertension in children with sickle cell disease.

Pulmonary hypertension in children with sickle cell disease.

http://www.wikidata.org/entity/Q37867674

about

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.

P2860

Q46609458-B40A735C-0CB9-4AB1-AE39-A61838A81FB0

P2860

Pulmonary hypertension in children with sickle cell disease.

http://www.wikidata.org/entity/Q37867674

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pulmonary hypertension in children with sickle cell disease.

@en

Pulmonary hypertension in children with sickle cell disease.

@nl

type

label

Pulmonary hypertension in children with sickle cell disease.

@en

Pulmonary hypertension in children with sickle cell disease.

@nl

prefLabel

Pulmonary hypertension in children with sickle cell disease.

@en

Pulmonary hypertension in children with sickle cell disease.

@nl

P1433

Q37867674-67B48EC6-DCF8-4B74-BD7E-1E8EE3CE8F4B

P1476

Q37867674-55EEAB67-6570-4E4D-A10A-445C2AD27E6D

P2093

Q37867674-9C18B1D8-8F5E-4AAD-8CD4-1ED0BD43772E

P2860

Q37867674-026B58CA-F278-4FA1-A54C-F5C02AC1074A

Q37867674-026CF25D-B00E-410A-88C6-C7BA5580E78E

Q37867674-03519151-5511-44AC-9607-3347F36520F5

Q37867674-04FE970F-5739-41B0-B1C9-FED884FEC8E9

Q37867674-0D5CB1AD-5898-4508-9AA9-0032CCF09102

Q37867674-14747562-9671-49B7-8D4C-4EF6A96EE366

Q37867674-1F7A5A7C-5AFF-4CAB-8265-4F91EC0A289C

Q37867674-20928642-D605-407C-8762-E32735507C7A

Q37867674-2596F8D1-28E9-4724-97FB-B216F986AB6F

Q37867674-29E1BF54-C3E8-4672-91CA-45D88A599029

P304

Q37867674-B5C3B6A2-F33E-4B1D-B2A8-0724EEE015FB

P31

Q37867674-56D3767D-0C98-46D1-B2BB-307D9B99145D

P356

Q37867674-C2482F70-2676-4A4E-AA29-0C2553E9C54F

P433

Q37867674-09BF54C7-F4A6-4978-9FE3-126A16930E79

P478

Q37867674-B1787A38-A3C6-4D95-9A5B-9672C30D4130

P50

Q37867674-12E434F0-99F0-4F4F-AAC3-77D3D35F4070

P577

Q37867674-70575FAF-8D8E-4474-87E8-8BCB208695B5

P698

Q37867674-61C64B8F-730A-4078-89EF-D3A5CA58FA66

P921

Q37867674-EC23EFEA-87C6-429A-9E15-B656B319D6DC

P356

P1433

Expert Review of Respiratory Medicine

P1476

Pulmonary hypertension in children with sickle cell disease

@en

P2093

Warren A Zuckerman

http://www.w3.org/2001/XMLSchema#string

P2860

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

Updated clinical classification of pulmonary hypertension.

Airway hyperresponsiveness in children with sickle cell anemia.

Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies.

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

P304

233-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERS.11.6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Erika Berman-Rosenzweig

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21510733

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease